These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11510053)

  • 1. [Betaserk efficiency in cochlear and vestibular disorders in the regional surdocenter].
    Pekaskiĭ SI
    Vestn Otorinolaringol; 2001; (3):61. PubMed ID: 11510053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of betaserk in patients with cochlear-vestibular disorders].
    Kadymov MI; Poliakova TS; Vladimirova TN
    Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Betaserk in therapy of cochleovestibular disordes].
    Khrapko NS; Sedykh MI; As'kova LN; Tarasova NV; Velikanov AK; Baryshevskaia LA
    Vestn Otorinolaringol; 2006; (4):59-60. PubMed ID: 17152479
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of betaserk in combined treatment of neurosensory hypoacusis and vestibulopathy in childhood].
    Chistiakova VR
    Vestn Otorinolaringol; 2004; (2):9-12. PubMed ID: 15111941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vestibo in the treatment of cochleovestibular disorders].
    Kunel'skaia NL; Levina IuV; Doronina OM; Krasiuk AA; Izotova GN
    Vestn Otorinolaringol; 2008; (6):52-4. PubMed ID: 19209416
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vestibular disorders in patients with otosclerosis: prevalence, diagnostic and therapeutic options].
    Morozova SV; Dobrotin VE; Kulakova LA; Kaspranskaia GR; Ovchinnikov IuM
    Vestn Otorinolaringol; 2009; (2):20-2. PubMed ID: 19491792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Betahistine in the treatment of vestibular and coordination disturbances in multiple sclerosis].
    Popova NF; Chugunova MA; Kunel'skaia NL; Shagaev AS; Boĭko AN; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):77-81. PubMed ID: 21916160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Betaserk in the treatment of aftereffects of craniocerebral injury and vascular events].
    Odinak MM; Kovalenko AP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):55-7. PubMed ID: 16117150
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rehabilitation of patients with peripheral vestibular disorders].
    Morozova SV; Zaĭtseva OV
    Vestn Otorinolaringol; 2004; (2):59-61. PubMed ID: 15139364
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of betaserk in experimental motor disease].
    Mantsev EI; Sigaleva EE
    Vestn Otorinolaringol; 2005; (6):49-52. PubMed ID: 16353011
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological correction of cochleovestibular impairments].
    Pal'chun VT; Poliakova TS; Kunel'skaia NA; Bogdanets SA
    Vestn Otorinolaringol; 2004; (4):36-9. PubMed ID: 15496841
    [No Abstract]   [Full Text] [Related]  

  • 12. Betahistine in the treatment of tinnitus in patients with vestibular disorders.
    Ganança MM; Caovilla HH; Gazzola JM; Ganança CF; Ganança FF
    Braz J Otorhinolaryngol; 2011; 77(4):499-503. PubMed ID: 21860977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The estimation of the efficacy of manual therapy included in the combined treatment of cochlear-vestibular disorders based on the results of computed stabilography].
    Shempeleva AÉ; Lopatin AS; Morozova SV; Gridin LA
    Vestn Otorinolaringol; 2012; (2):45-8. PubMed ID: 22810637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vestibular disorders and methods for their correction].
    Mironenko TV
    Lik Sprava; 2003 Dec; (8):72-6. PubMed ID: 14965013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose- and duration-dependent effects of betahistine dihydrochloride treatment on histamine turnover in the cat.
    Tighilet B; Trottier S; Lacour M
    Eur J Pharmacol; 2005 Oct; 523(1-3):54-63. PubMed ID: 16226741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trimetazidine therapy in atrio-cochlear disturbances of vascular origin].
    Kozakiewicz K; Wróbel M; Petelenz T; Lepkowski A; Skrzypek-Wańha J; Chruściel TL
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):327-9. PubMed ID: 8415248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the quality of life in patients with vestibular disorders: the role of medical treatments and physical rehabilitation.
    Mira E
    Int J Clin Pract; 2008 Jan; 62(1):109-14. PubMed ID: 17537195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Betaserc in the treatment of vestibular dysfunctions of different etiology].
    Nalimova TA; Kolenova IE
    Vestn Otorinolaringol; 2006; (1):57-8. PubMed ID: 16482015
    [No Abstract]   [Full Text] [Related]  

  • 19. [Betaserc treatment of acute disorders of cerebral circulation with vestibulo-ataxic and cochleo-vestibular syndromes].
    Berdichevskiĭ MIa; Karmirian SA; Geĭko II; Miroshnichenko VE; Parkhaeva TN; Popova VG; Timchenko LV; Filina TV; Aristova LA
    Vestn Otorinolaringol; 2002; (4):32-3. PubMed ID: 12400131
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cavinton in the treatment of cochleovestibular disorders of vascular genesis].
    Kunel'skaia NL; Gulieva AE; Ianiushkina ES; Chugunova MI
    Vestn Otorinolaringol; 2009; (5):52-4. PubMed ID: 20041504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.